Alavert and Cevimeline drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alavert (loratadine) and Cevimeline (cevimeline hydrochloride). Common drug interactions include anxiety among females.

The phase IV clinical study analyzes what interactions people have when they take Alavert and Cevimeline. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Alavert?

Alavert has active ingredients of loratadine. It is often used in allergies. eHealthMe is studying from 2,062 Alavert users. Check the latest studies of Alavert.

What is Cevimeline?

Cevimeline has active ingredients of cevimeline hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,480 Cevimeline users. Check the latest studies of Cevimeline.



On Jul, 30, 2026

15 people who take Alavert and Cevimeline together, and have interactions are studied.

Alavert and Cevimeline drug interactions.

What are the common drug interactions of Alavert and Cevimeline, by gender? *:

female:

  1. Anxiety
  2. Blood copper increased
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Back disorder
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Chest pain
  8. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  9. Dizziness
  10. Drug hypersensitivity

male:

n/a

What are the common drug interactions of Alavert and Cevimeline, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anxiety
  2. Blood copper increased
  3. Asthenia (weakness)
  4. Back disorder
  5. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  6. Dermatitis contact (skin reaction (dermatitis) resulting from exposure to allergens)
  7. Dizziness
  8. Dry eye (lack of adequate tears)
  9. Dry mouth
  10. Fall

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 13 people, 86.67%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 86.67%
  3. Drowsiness: 3 people, 20.00%
  4. Lichen Myxoedematosus (deposition of acid mucopolysaccharides in the skin): 2 people, 13.33%
  5. Hypersensitivity: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Alavert and Cevimeline?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Alavert and Cevimeline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Alavert:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cevimeline:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Alavert and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cevimeline and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on loratadine and cevimeline hydrochloride (the active ingredients of Alavert and Cevimeline, respectively), and Alavert and Cevimeline (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: